The Biden administration is supporting Pfizer Inc.’s move to begin exporting U.S.-made doses of its coronavirus vaccine, as the White House starts to open up production for shot-starved nations abroad.
“We are glad to see that they are working with other countries to help them meet their supply needs,” Jeff Zients, President Joe Biden’s COVID-19 response coordinator, told Bloomberg News in a statement. He said the company is ahead of schedule in its commitments to supply the U.S.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.